|1.||Clayton, Natasha P: 2 articles (07/2015 - 01/2005)|
|2.||Iatropoulos, Michael J: 2 articles (12/2014 - 03/2013)|
|3.||Williams, Gary M: 2 articles (12/2014 - 03/2013)|
|4.||Jeffrey, Alan M: 2 articles (12/2014 - 03/2013)|
|5.||Gruebbel, Margarita: 1 article (07/2015)|
|6.||Tabakoff, Boris: 1 article (07/2015)|
|7.||Herbert, Ronald A: 1 article (07/2015)|
|8.||Heinbockel, Thomas: 1 article (07/2015)|
|9.||Olson, David: 1 article (07/2015)|
|10.||Hurlburt, Geoffrey: 1 article (07/2015)|
08/01/2010 - "Methyleugenol reduces cerebral ischemic injury by suppression of oxidative injury and inflammation."
08/01/2010 - "The results indicate that methyleugenol could be useful for the treatment of ischemia/inflammation-related diseases."
01/01/2015 - "Inhibitory effect of methyleugenol on IgE-mediated allergic inflammation in RBL-2H3 cells."
04/01/2001 - "In rats, methyleugenol caused an increase in the incidences of hepatocyte cytologic alteration, cytomegaly, Kupffer cell pigmentation, mixed foci of cellular alteration and bile duct hyperplasia of the liver and atrophy and chronic inflammation of the mucosa of the glandular stomach. "
09/01/2011 - "Methyleugenol (MEG), a constituent of human food, induces malignant tumors in multiple tissues of rats and mice. "
05/01/2004 - "The resulting graph for methyl eugenol showed a linear response for both adduct formation and tumor incidence. "
07/01/2015 - "Methyl eugenol induces neuroendocrine (NE) cell hyperplasia and tumors in F344/N rat stomach. "
01/01/2015 - "Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines."
12/01/2014 - "These results suggest that tumor formation could be lower in rodent bioassays when methyleugenol would be dosed in a matrix containing SULT inhibitors such as nevadensin compared to experiments using the pure methyleugenol. "
01/01/2010 - "Dose response modelling of the data for methyleugenol gave a BMDL10 for male rat liver adenoma or carcinoma (combined) of 7.9 mg/kg-bw/d following adjustment to daily average doses. "
01/01/2013 - "Plant polyphenols and oxidative metabolites of the herbal alkenylbenzene methyleugenol suppress histone deacetylase activity in human colon carcinoma cells."
12/01/1984 - "When a series of nine alkenylbenzenes were administered to preweanling male mice, safrole, estragole and methyleugenol induced a significant incidence of hepatic carcinomas, while eugenol, anethole, elemicin, myristicin, dill apiol and parsley apiol did not (Miller et al., Cancer Res., 43, 1124-1134, 1983). "
07/01/2015 - "Methyl eugenol is a major active component extracted from the Chinese herb Asari Radix et Rhizoma, which has been used to treat toothache and other pain. "
12/28/2006 - "Methyleugenol also inhibited pain-related behaviors induced by intrathecal injection of N-methyl-d-aspartic acid (NMDA), while diclofenac did not affect these behaviors. "
12/28/2006 - "These results suggest that the antinociceptive effect of methyleugenol on the second phase of formalin-induced pain may be due to the inhibition of NMDA receptor-mediated hyperalgesia via GABA(A) receptors."
|5.||Immunoglobulin E (IgE)